Stock Scorer

Moelis & Co (MC) · Insider trading

What Moelis's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$638,073
2 insiders, 0% under a plan
Net, 12 months
−$638,073
bought less sold
Latest filing
2026-09-21
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $70,800 sold 2025-01 2025-02: $4.67M sold 2025-07: $460,538 sold 2025-07 2025-08: $189,640 sold 2026-01 2026-02: $172,066 sold 2026-07 2026-08: $466,007 sold
Bought Sold Largest month: $4.67M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Watanabe Osamu R.General Counsel, Secretary – $1.39M 4 2026-08-04 131
Cantor EricDirector, Vice Chairman, MD – $1.22M 1 2025-02-19 218,805
Moelis KennethDirector, Chairman, CEO – $718,688 1 2025-02-19 209,235
Mahmoodzadegan NavidCo-President, MD – $696,044 1 2025-02-19 197,602
Raich JeffreyCo-President, MD – $645,428 1 2025-02-19 54,794
Shropshire KennethDirector – $503,979 3 2026-08-27 7,633
Simon JosephChief Financial Officer – $426,092 1 2025-02-19 22,832
Pilcher Ciafone KatherineChief Operating Officer – $260,110 1 2025-02-19 3,934
Callesano ChristopherPrincipal Accounting Officer – $165,668 2 2025-02-19 1,227

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-08-27 Shropshire KennethDirector Sale 1,881 69.06 $129,902 7,633 Form 4
2026-08-04 Watanabe Osamu R.General Counsel, Secretary Sale 4,850 69.30 $336,105 131 Form 4
2026-02-19 Watanabe Osamu R.General Counsel, Secretary Sale 2,765 62.23 $172,066 4,981 Form 4
2025-08-22 Shropshire KennethDirector Sale 2,615 72.52 $189,640 7,109 Form 4
2025-07-25 Watanabe Osamu R.General Counsel, Secretary Sale 6,340 72.64 $460,538 131 Form 4
2025-02-21 Shropshire KennethDirector Sale 2,551 72.30 $184,437 6,940 Form 4
2025-02-19 Mahmoodzadegan NavidCo-President, MD Sale 9,406 74.00 $696,044 197,602 Form 4
2025-02-19 Watanabe Osamu R.General Counsel, Secretary Sale 5,661 74.00 $418,914 6,471 Form 4
2025-02-19 Raich JeffreyCo-President, MD Sale 8,722 74.00 $645,428 54,794 Form 4
2025-02-19 Callesano ChristopherPrincipal Accounting Officer Sale 1,282 74.00 $94,868 1,227 Form 4
2025-02-19 Moelis KennethDirector, Chairman, CEO Sale 9,712 74.00 $718,688 209,235 Form 4
2025-02-19 Simon JosephChief Financial Officer Sale 5,758 74.00 $426,092 22,832 Form 4
2025-02-19 Cantor EricDirector, Vice Chairman, MD Sale 16,530 74.00 $1.22M 218,805 Form 4
2025-02-19 Pilcher Ciafone KatherineChief Operating Officer Sale 3,515 74.00 $260,110 3,934 Form 4
2024-11-07 Callesano ChristopherPrincipal Accounting Officer Sale 885 80.00 $70,800 0 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

88 × grant or award24 × option exercise17 × shares withheld for tax
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-17 Shropshire KennethDirector Grant or award A +20 – 1,852 Form 4
2026-09-17 Shropshire KennethDirector Grant or award A +19 – 1,719 Form 4
2026-09-17 Shropshire KennethDirector Grant or award A +2 – 202 Form 4
2026-09-17 Worrell LailaDirector Grant or award A +19 – 1,768 Form 4
2026-09-17 Worrell LailaDirector Grant or award A +18 – 1,641 Form 4
2026-09-17 Worrell LailaDirector Grant or award A +19 – 1,796 Form 4
2026-09-17 Mirrer LouiseDirector Grant or award A +19 – 1,768 Form 4
2026-09-17 Mirrer LouiseDirector Grant or award A +18 – 1,641 Form 4
2026-09-17 Barker ThoroldDirector Grant or award A +18 – 1,683 Form 4
2026-09-17 Barker ThoroldDirector Grant or award A +17 – 1,562 Form 4
2026-07-01 Shropshire KennethDirector Grant or award A +1,700 – 1,700 Form 4
2026-07-01 Shropshire KennethDirector Grant or award A +200 – 200 Form 4
2026-07-01 Worrell LailaDirector Grant or award A +1,623 – 1,623 Form 4
2026-07-01 Worrell LailaDirector Grant or award A +1,777 – 1,777 Form 4
2026-07-01 Mirrer LouiseDirector Grant or award A +1,623 – 1,623 Form 4
2026-07-01 Barker ThoroldDirector Grant or award A +1,545 – 1,545 Form 4
2026-06-18 Worrell LailaDirector Grant or award A +20 – 2,095 Form 4
2026-06-18 Worrell LailaDirector Grant or award A +17 – 1,748 Form 4
2026-06-18 Worrell LailaDirector Grant or award A +5 – 480 Form 4
2026-06-18 Shropshire KennethDirector Grant or award A +21 – 2,195 Form 4
2026-06-18 Shropshire KennethDirector Grant or award A +18 – 1,832 Form 4
2026-06-18 Shropshire KennethDirector Grant or award A +1 – 54 Form 4
2026-06-18 Mirrer LouiseDirector Grant or award A +12 – 1,293 Form 4
2026-06-18 Mirrer LouiseDirector Grant or award A +0 – 40 Form 4
2026-06-18 Mirrer LouiseDirector Grant or award A +17 – 1,748 Form 4
2026-06-18 Barker ThoroldDirector Grant or award A +16 – 1,665 Form 4
2026-03-26 Mirrer LouiseDirector Grant or award A +15 – 1,280 Form 4
2026-03-26 Mirrer LouiseDirector Grant or award A +0 – 40 Form 4
2026-03-26 Mirrer LouiseDirector Grant or award A +20 – 1,732 Form 4
2026-03-26 Barker ThoroldDirector Grant or award A +19 – 1,649 Form 4
2026-03-26 Worrell LailaDirector Grant or award A +24 – 2,075 Form 4
2026-03-26 Worrell LailaDirector Grant or award A +20 – 1,732 Form 4
2026-03-26 Worrell LailaDirector Grant or award A +11 – 949 Form 4
2026-03-26 Shropshire KennethDirector Grant or award A +25 – 2,174 Form 4
2026-03-26 Shropshire KennethDirector Grant or award A +21 – 1,814 Form 4
2026-03-26 Shropshire KennethDirector Grant or award A +1 – 107 Form 4
2026-02-19 Cantor EricDirector, Vice Chairman, MD Option exercise M +32,368 – 251,173 Form 4
2026-02-19 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −14,225 62.73 236,948 Form 4
2026-02-19 Pilcher Ciafone KatherineChief Operating Officer Option exercise M +4,885 – 8,819 Form 4
2026-02-19 Pilcher Ciafone KatherineChief Operating Officer Shares withheld for tax F −850 62.73 7,969 Form 4
2026-02-19 Callesano ChristopherChief Financial Officer Option exercise M +2,179 – 3,406 Form 4
2026-02-19 Callesano ChristopherChief Financial Officer Shares withheld for tax F −1,114 62.73 2,292 Form 4
2026-02-19 Watanabe Osamu R.General Counsel, Secretary Option exercise M +9,219 – 9,350 Form 4
2026-02-19 Watanabe Osamu R.General Counsel, Secretary Shares withheld for tax F −1,604 62.73 7,746 Form 4
2026-02-19 Riehl NickPrincipal Accounting Officer Option exercise M +61 – 61 Form 4
2026-02-19 Riehl NickPrincipal Accounting Officer Shares withheld for tax F −25 62.73 36 Form 4
2025-12-05 Cantor EricDirector, Vice Chairman, MD Option exercise M +668 – 219,473 Form 4
2025-12-05 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −668 66.45 218,805 Form 4
2025-12-04 Mirrer LouiseDirector Grant or award A +12 – 1,266 Form 4
2025-12-04 Mirrer LouiseDirector Grant or award A +0 – 39 Form 4
2025-12-04 Mirrer LouiseDirector Grant or award A +17 – 1,712 Form 4
2025-12-04 Barker ThoroldDirector Grant or award A +16 – 1,630 Form 4
2025-12-04 Worrell LailaDirector Grant or award A +20 – 2,051 Form 4
2025-12-04 Worrell LailaDirector Grant or award A +17 – 1,712 Form 4
2025-12-04 Worrell LailaDirector Grant or award A +14 – 1,406 Form 4
2025-12-04 Shropshire KennethDirector Grant or award A +21 – 2,149 Form 4
2025-12-04 Shropshire KennethDirector Grant or award A +17 – 1,793 Form 4
2025-12-04 Shropshire KennethDirector Grant or award A +2 – 159 Form 4
2025-10-30 Moelis KennethDirector, Executive Chairman Option exercise M +73 – 209,310 Form 4
2025-09-18 Worrell LailaDirector Grant or award A +17 – 2,031 Form 4
2025-09-18 Worrell LailaDirector Grant or award A +14 – 1,695 Form 4
2025-09-18 Worrell LailaDirector Grant or award A +15 – 1,856 Form 4
2025-09-18 Mirrer LouiseDirector Grant or award A +10 – 1,253 Form 4
2025-09-18 Mirrer LouiseDirector Grant or award A +0 – 39 Form 4
2025-09-18 Mirrer LouiseDirector Grant or award A +14 – 1,695 Form 4
2025-09-18 Barker ThoroldDirector Grant or award A +13 – 1,614 Form 4
2025-09-18 Shropshire KennethDirector Grant or award A +18 – 2,128 Form 4
2025-09-18 Shropshire KennethDirector Grant or award A +15 – 1,776 Form 4
2025-09-18 Shropshire KennethDirector Grant or award A +2 – 210 Form 4
2025-07-14 Barker ThoroldDirector Grant or award A +1,601 – 1,601 Form 4
2025-07-01 Worrell LailaDirector Grant or award A +1,681 – 1,681 Form 4
2025-07-01 Worrell LailaDirector Grant or award A +1,841 – 1,841 Form 4
2025-07-01 Shropshire KennethDirector Grant or award A +1,761 – 1,761 Form 4
2025-07-01 Shropshire KennethDirector Grant or award A +208 – 208 Form 4
2025-07-01 Mirrer LouiseDirector Grant or award A +1,681 – 1,681 Form 4
2025-06-20 Mirrer LouiseDirector Grant or award A +14 – 1,243 Form 4
2025-06-20 Mirrer LouiseDirector Grant or award A +0 – 38 Form 4
2025-06-20 Shropshire KennethDirector Grant or award A +30 – 2,661 Form 4
2025-06-20 Shropshire KennethDirector Grant or award A +24 – 2,110 Form 4
2025-06-20 Shropshire KennethDirector Grant or award A +1 – 62 Form 4
2025-06-20 Worrell LailaDirector Grant or award A +29 – 2,540 Form 4
2025-06-20 Worrell LailaDirector Grant or award A +23 – 2,015 Form 4
2025-06-20 Worrell LailaDirector Grant or award A +3 – 277 Form 4
2025-05-01 Mirrer LouiseDirector Grant or award A +38 – 38 Form 4
2025-03-27 Shropshire KennethDirector Grant or award A +28 – 2,631 Form 4
2025-03-27 Shropshire KennethDirector Grant or award A +22 – 2,086 Form 4
2025-03-27 Shropshire KennethDirector Grant or award A +1 – 123 Form 4
2025-03-27 Worrell LailaDirector Grant or award A +27 – 2,512 Form 4
2025-03-27 Worrell LailaDirector Grant or award A +21 – 1,992 Form 4
2025-03-27 Worrell LailaDirector Grant or award A +6 – 546 Form 4
2025-03-27 Mirrer LouiseDirector Grant or award A +13 – 1,229 Form 4
2025-03-07 Moelis KennethDirector, Chairman, CEO Option exercise M +2 – 209,237 Form 4
2025-02-19 Mahmoodzadegan NavidCo-President, MD Option exercise M +57,009 – 207,009 Form 4
2025-02-19 Mahmoodzadegan NavidCo-President, MD Shares withheld for tax F −1 74.00 207,008 Form 4
2025-02-19 Watanabe Osamu R.General Counsel, Secretary Option exercise M +12,004 – 12,135 Form 4
2025-02-19 Watanabe Osamu R.General Counsel, Secretary Shares withheld for tax F −3 74.00 12,132 Form 4
2025-02-19 Raich JeffreyCo-President, MD Option exercise M +18,758 – 63,517 Form 4
2025-02-19 Raich JeffreyCo-President, MD Shares withheld for tax F −1 74.00 63,516 Form 4
2025-02-19 Callesano ChristopherPrincipal Accounting Officer Option exercise M +2,511 – 2,511 Form 4
2025-02-19 Callesano ChristopherPrincipal Accounting Officer Shares withheld for tax F −2 74.00 2,509 Form 4
2025-02-19 Moelis KennethDirector, Chairman, CEO Option exercise M +58,861 – 218,948 Form 4
2025-02-19 Moelis KennethDirector, Chairman, CEO Shares withheld for tax F −1 74.00 218,947 Form 4
2025-02-19 Simon JosephChief Financial Officer Option exercise M +11,824 – 28,591 Form 4
2025-02-19 Simon JosephChief Financial Officer Shares withheld for tax F −1 74.00 28,590 Form 4
2025-02-19 Cantor EricDirector, Vice Chairman, MD Option exercise M +37,612 – 235,336 Form 4
2025-02-19 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −2 74.00 235,335 Form 4
2025-02-19 Pilcher Ciafone KatherineChief Operating Officer Option exercise M +7,451 – 7,451 Form 4
2025-02-19 Pilcher Ciafone KatherineChief Operating Officer Shares withheld for tax F −2 74.00 7,449 Form 4
2025-02-18 Moelis KennethDirector, Chairman, CEO Option exercise M +160,000 – 160,086 Form 4
2025-02-18 Moelis KennethDirector, Chairman, CEO Option exercise M +1 – 160,087 Form 4
2025-02-18 Mahmoodzadegan NavidCo-President, MD Option exercise M +150,000 – 150,000 Form 4
2025-02-18 Raich JeffreyCo-President, MD Option exercise M +44,759 – 44,759 Form 4
2025-02-18 Simon JosephChief Financial Officer Option exercise M +16,767 – 16,767 Form 4
2025-02-06 Cantor EricDirector, Vice Chairman, MD Option exercise M +876 – 198,109 Form 4
2025-02-06 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −385 79.68 197,724 Form 4
2024-12-03 Cantor EricDirector, Vice Chairman, MD Option exercise M +1,356 – 198,589 Form 4
2024-12-03 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −1,356 75.81 197,233 Form 4
2024-12-02 Mirrer LouiseDirector Grant or award A +10 – 1,216 Form 4
2024-12-02 Worrell LailaDirector Grant or award A +20 – 2,484 Form 4
2024-12-02 Worrell LailaDirector Grant or award A +15 – 1,970 Form 4
2024-12-02 Worrell LailaDirector Grant or award A +6 – 809 Form 4
2024-12-02 Allison John ADirector Grant or award A +20 – 2,484 Form 4
2024-12-02 Allison John ADirector Grant or award A +15 – 1,970 Form 4
2024-12-02 Allison John ADirector Grant or award A +6 – 809 Form 4
2024-12-02 Shropshire KennethDirector Grant or award A +20 – 2,603 Form 4
2024-12-02 Shropshire KennethDirector Grant or award A +16 – 2,064 Form 4
2024-12-02 Shropshire KennethDirector Grant or award A +1 – 183 Form 4
2024-10-24 Cantor EricDirector, Vice Chairman, MD Option exercise M +890 – 197,624 Form 4
2024-10-24 Cantor EricDirector, Vice Chairman, MD Shares withheld for tax F −391 68.24 197,233 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Moelis's scores and multiples ›